Breathing platform for relaxatio

Completed

• Conditions: Sleep; Respiratory - Other respiratory disorders / diseases

• Registration Number: ACTRN12618000709246
• Lead Sponsor: ResMed

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2018-05-01
• Study Completion: 2018-07-13
• Last Update Posted: 28 January 2019

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 10

Inclusion Criteria

•Participants are willing to give written, informed consent
•Participants are healthy adults
•Participants are able to comprehend and speak English
•Participants are at least 18 years of age

Exclusion Criteria

•Participants who are/may be pregnant or lactating
•Participants that have a pre-existing lung disease/ condition that would predispose them to pneumothorax (for example: COPD; lung cancer; fibrosis of the lungs; recent (< 2years) case of pneumonia or lung infection; lung injury)
•Participants who are unsuitable for the inclusion at the discretion of the investigator

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Assess the usability of the system assessed by scores allocated by participants regarding the ease of use (scale from 1-10). [Usability will be assessed halfway (day 5) during the trial and at the completion of the study (after day 8 - primary timepoint).]

Secondary Outcome Measures

Name	Time	Method
Compliance to treatment will be assessed in an interview between the participant and investigator.[Interview will be held at the completion of the study - day 9]